Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$34.07
-2.95%
Mkt Cap $1.55B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $525.00K | — | — | -$0.51 | -$0.62 | -21.57% | — | — |
| Q4 2025 Nov 10, 2025 | $600.00K | — | — | -$0.54 | -$0.54 | +0.00% | — | — |
| Q3 2025 Aug 11, 2025 | $480.00K | — | — | -$0.48 | -$0.57 | -18.75% | — | — |
| Q2 2025 May 13, 2025 | $3.16M | — | — | -$0.33 | -$0.53 | -60.61% | — | — |
| Q1 2025 Mar 19, 2025 | $5.50M | $11.13M | +102.37% | -$0.31 | -$0.16 | +48.39% | — | — |
| Q4 2024 Nov 13, 2024 | $9.87M | $2.26M | -77.09% | -$0.36 | -$0.38 | -5.56% | — | — |
| Q3 2024 Aug 7, 2024 | $3.58M | $3.97M | +10.93% | -$0.36 | -$0.35 | +2.78% | — | — |
| Q2 2024 May 13, 2024 | $9.70M | $4.91M | -49.41% | -$0.11 | -$0.31 | -181.82% | — | — |
| Q1 2024 Feb 29, 2024 | $10.60M | $12.09M | +14.04% | -$0.09 | -$0.02 | +77.78% | — | — |
| Q4 2023 Nov 14, 2023 | $10.90M | $6.19M | -43.25% | -$0.29 | -$0.25 | +13.79% | — | — |
| Q3 2023 Aug 7, 2023 | $1.50M | $3.92M | +161.16% | -$0.35 | -$0.29 | +17.14% | — | — |
| Q2 2023 May 11, 2023 | $500.00K | $2.99M | +497.34% | -$0.32 | -$0.31 | +3.13% | — | — |
| Q1 2023 Mar 15, 2023 | $10.00K | $959.90K | +9499.03% | -$0.33 | -$0.31 | +6.06% | — | — |
| Q4 2022 Nov 10, 2022 | $420.00K | $1.59M | +278.94% | -$0.29 | -$0.26 | +10.34% | — | — |
| Q3 2022 Aug 10, 2022 | $390.00K | — | — | -$0.25 | -$0.29 | -16.00% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | — | -$0.32 | — | — | — |
| Q1 2022 Mar 10, 2022 | — | -$244.65K | — | -$0.19 | -$0.26 | -36.84% | — | — |
| Q4 2021 Nov 9, 2021 | $210.00K | — | — | -$0.22 | -$0.17 | +22.73% | — | — |
| Q3 2021 Aug 12, 2021 | $221.83K | $204.08K | -8.00% | -$0.23 | -$0.21 | +8.70% | — | — |
| Q2 2021 May 13, 2021 | — | $40.82K | — | — | -$0.23 | — | — | — |